⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Bile Acid–FXR–TGR5 Axis in Hepatic Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-21 — β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.: cross-connection with nampt-nad-biosynthesis: First causal link between oral NAD+ precursor supplementation and FXR-driven bile acid remodeling in a hepatotoxic-stress model, bridging NAD biosynthesis and the bile-acid–FXR hepatic aging axis. (novelty: 3)
Open questions
Related
Contributing findings
Bile acids as a "new hormone" in aging-related liver disease.
07-aug-2026
novelty 2
per-area 3
introduces